Regeneron Pharmaceuticals Inc (REGN)
621.13
+3.02 (+0.49%)
USD |
NASDAQ |
Jan 20, 09:35
Regeneron Pharmaceuticals Price: 621.13 for Jan. 20, 2022
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jan 19, 2022 | 617.01 | 628.05 | 612.40 | 618.11 | 649135.0 |
| Jan 18, 2022 | 604.52 | 612.39 | 598.13 | 611.22 | 975003.0 |
| Jan 14, 2022 | 616.02 | 623.20 | 604.80 | 615.24 | 791993.0 |
| Jan 13, 2022 | 632.75 | 632.75 | 614.15 | 616.11 | 649326.0 |
| Jan 12, 2022 | 624.45 | 632.39 | 620.83 | 631.44 | 584744.0 |
| Jan 11, 2022 | 623.19 | 628.08 | 617.76 | 626.09 | 613780.0 |
| Jan 10, 2022 | 603.75 | 621.61 | 602.13 | 621.27 | 822757.0 |
| Jan 07, 2022 | 598.44 | 607.01 | 592.86 | 603.73 | 584376.0 |
| Jan 06, 2022 | 600.00 | 606.02 | 594.97 | 598.44 | 676252.0 |
| Jan 05, 2022 | 604.95 | 613.65 | 594.99 | 595.12 | 1.101M |
| Jan 04, 2022 | 622.95 | 625.07 | 612.11 | 616.82 | 725442.0 |
| Jan 03, 2022 | 625.00 | 629.33 | 621.87 | 627.10 | 515573.0 |
| Dec 31, 2021 | 644.34 | 645.50 | 630.66 | 631.52 | 353395.0 |
| Dec 30, 2021 | 647.15 | 651.28 | 642.28 | 642.51 | 306343.0 |
| Dec 29, 2021 | 639.47 | 649.00 | 638.75 | 647.28 | 412968.0 |
| Dec 28, 2021 | 637.04 | 639.50 | 635.00 | 638.46 | 327754.0 |
| Dec 27, 2021 | 625.66 | 636.36 | 623.29 | 634.77 | 443681.0 |
| Dec 23, 2021 | 619.50 | 627.22 | 618.15 | 625.38 | 398736.0 |
| Dec 22, 2021 | 608.47 | 619.24 | 600.85 | 617.48 | 737448.0 |
| Dec 21, 2021 | 608.58 | 608.58 | 598.24 | 606.81 | 1.109M |
| Dec 20, 2021 | 620.70 | 625.35 | 602.07 | 603.14 | 912201.0 |
| Dec 17, 2021 | 631.04 | 631.16 | 615.20 | 619.28 | 1.628M |
| Dec 16, 2021 | 644.74 | 656.34 | 630.10 | 631.74 | 1.242M |
| Dec 15, 2021 | 646.99 | 662.63 | 645.00 | 657.93 | 842074.0 |
| Dec 14, 2021 | 652.23 | 673.86 | 651.89 | 670.97 | 730766.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
273.46
Minimum
Sep 27 2019
680.96
Maximum
Sep 01 2021
444.32
Average
415.60
Median
Price Benchmarks
| Moderna Inc | 173.07 |
| Gilead Sciences Inc | 68.73 |
| Johnson & Johnson | 166.80 |
| Eli Lilly and Co | 243.98 |
| Merck & Co Inc | 80.72 |
Price Related Metrics
| PE Ratio | 9.917 |
| PS Ratio | 5.129 |
| PEG Ratio | 0.0770 |
| Price to Book Value | 3.871 |
| Price to Free Cash Flow | 12.91 |
| Earnings Yield | 10.08% |
| Market Cap | 66.80B |
| PEGY Ratio | 0.0770 |
| Operating PE Ratio | 9.293 |
| Normalized PE Ratio | 9.917 |